KYBRISQ Trademark

Trademark Overview


On Monday, June 2, 2014, a trademark application was filed for KYBRISQ with the United States Patent and Trademark Office. The USPTO has given the KYBRISQ trademark a serial number of 79151496. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, March 4, 2022. This trademark is owned by SHIONOGI & CO., LTD.. The KYBRISQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, thrombocytopenia, disease and disorders of the liver, and opioid-induced constipation; pharmaceutical preparations for treating allergic rhinitis
kybrisq

General Information


Serial Number79151496
Word MarkKYBRISQ
Filing DateMonday, June 2, 2014
Status709 - CANCELLED - SECTION 71
Status DateFriday, March 4, 2022
Registration Number4792455
Registration DateTuesday, August 18, 2015
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 2, 2015

Trademark Statements


Description of MarkThe mark consists of the wording "KYBRISQ" in a stylized font.
Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammation and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, thrombocytopenia, disease and disorders of the liver, and opioid-induced constipation; pharmaceutical preparations for treating allergic rhinitis
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSHIONOGI & CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameSHIONOGI & CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameSHIONOGI & CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Tuesday, December 27, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, November 30, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, November 30, 2022INVALIDATION PROCESSED
Friday, November 4, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 4, 2022CANCELLED SECTION 71
Saturday, February 20, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 2, 2016FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, February 2, 2016FINAL DISPOSITION PROCESSED
Wednesday, November 18, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 18, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 2, 2015NOTIFICATION PROCESSED BY IB
Tuesday, June 2, 2015PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 13, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 13, 2015NOTICE OF PUBLICATION
Friday, April 24, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 14, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 23, 2015ASSIGNED TO LIE
Friday, March 13, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 3, 2014REFUSAL PROCESSED BY IB
Wednesday, September 17, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 17, 2014REFUSAL PROCESSED BY MPU
Wednesday, September 17, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 16, 2014NON-FINAL ACTION WRITTEN
Monday, September 15, 2014ASSIGNED TO EXAMINER
Tuesday, September 9, 2014APPLICATION FILING RECEIPT MAILED
Wednesday, September 3, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 2, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 28, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB